Yüklüyor......
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study
OBJECTIVES: Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed. We hypothesized that colchicine, by counteracting proinflammatory pathways implicated in the uncontrolled inflammatory response of COVID-19 patients, reduces pulmonary complications, and improves survival....
Kaydedildi:
| Yayımlandı: | PLoS One |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7990208/ https://ncbi.nlm.nih.gov/pubmed/33760858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0248276 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|